Bruton C J, Crow T J, Frith C D, Johnstone E C, Owens D G, Roberts G W
Department of Neuropathology, Runwell Hospital, Wickford, Essex.
Psychol Med. 1990 May;20(2):285-304. doi: 10.1017/s0033291700017608.
The neuropathological results from a prospective, systematically assessed, series of 56 schizophrenic patients and 56 age- and sex-matched normal controls have been presented. When compared with the normal controls, the brains of the schizophrenic subjects showed a significant reduction in brain weight and brain length with a concomitant increase in ventricular size. (All findings relate to measurements made after formalin fixation). In addition, the brains of the schizophrenic patients contained significantly more non-specific focal pathology and fibrillary gliosis than the controls. After exclusion of cases with moderate and severe Alzheimer-type change, cerebro-vascular disease and all forms of focal pathology, the structural brain changes (i.e. decrease in brain weight and brain length) continued to distinguish the schizophrenia group from the controls. Furthermore, an analysis of the clinical data showed that the structural brain changes were correlated in the schizophrenic patients with a measurement of pre-morbid function. The findings and their possible aetiological implications have been discussed.
本文呈现了对56例精神分裂症患者及56例年龄和性别匹配的正常对照者进行的前瞻性、系统评估系列研究的神经病理学结果。与正常对照者相比,精神分裂症患者的大脑显示脑重量和脑长度显著减少,同时脑室大小增加。(所有结果均为福尔马林固定后的测量值)。此外,精神分裂症患者的大脑中非特异性局灶性病变和纤维性胶质增生明显多于对照组。排除中度和重度阿尔茨海默病型改变、脑血管疾病及所有形式的局灶性病变病例后,大脑结构改变(即脑重量和脑长度减少)仍可区分精神分裂症组和对照组。此外,对临床数据的分析表明,精神分裂症患者的大脑结构改变与病前功能测量值相关。文中讨论了这些发现及其可能的病因学意义。